SC
EDIT icon

SouthState Corp’s Editas Medicine EDIT Stock Holding History

SouthState Corp’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-500
Closed -$580 – 1658
2025
Q1 		$580 Hold
500
– – ﹤0.01% 1460
2024
Q4 		$635 Hold
500
– – ﹤0.01% 654
2024
Q3 		$1.71K Hold
500
– – ﹤0.01% 573
2024
Q2 		$2.33K Buy
+500
New +$2.82K ﹤0.01% 587

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SouthState Corp's EDIT Position: Q2 2025 in Review

SouthState Corp sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 500 shares — an estimated $580 sold.

SouthState Corp first reported a position in EDIT in Q2 2024 and held it in 4 quarters. The position peaked at $2.33K in Q2 2024. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • SouthState Corp reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
  • SouthState Corp sold 500 Editas Medicine shares in Q2 2025, an estimated $580.
  • SouthState Corp first reported a position in Editas Medicine in Q2 2024 and held it in 4 quarters.
  • SouthState Corp's Editas Medicine position peaked at $2.33K in Q2 2024.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on SouthState Corp's 13F filing for Q2 2025, filed 6 Aug 2025.